THE ECONOMIC IMPLICATIONS OF RASBURICASE TREATMENT IN ADULT TUMOR LYSIS SYNDROME PATIENTS

被引：0
|
作者：
Eaddy, M. [1 ]
Seal, B. [2 ]
Tangirala, M. [3 ]
O'Day, K. [1 ]
机构：
[1] Xcenda, Palm Harbor, FL USA
[2] Sanofi Aventis, Bridgewater, NJ USA
[3] Smith Harley Consulting Grp LLC, Lake Mary, FL USA
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)73261-7
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A40 / A40
页数：1
相关论文
共 50 条
  • [1] The economic implications of rasburicase treatment in adult tumor lysis syndrome patients
    Eaddy, M.
    O'Day, K.
    Tangirala, K. M.
    Seal, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] Economic Implications of Rasburicase Treatment in Adult Patients with Tumour Lysis Syndrome
    Eaddy, Michael
    Seal, Brian
    Tangirala, Krishna
    Davies, Elizabeth
    O'Day, Ken
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2012, 10 (06) : 431 - 440
  • [3] Economic Implications of Rasburicase Treatment in Adult Patients with Tumour Lysis Syndrome
    Michael Eaddy
    Brian Seal
    Krishna Tangirala
    Elizabeth Hackney Davies
    Ken O’Day
    Applied Health Economics and Health Policy, 2012, 10 (6) : 431 - 440
  • [4] The economic implications of rasburicase treatment in pediatric tumor lysis syndrome patients
    O'Day, K.
    Eaddy, M.
    Seal, B.
    Tangirala, K. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] Economic comparison of rasburicase and allopurinol for treatment of tumor lysis syndrome in pediatric patients
    Eaddy, Michael
    Seal, Brian
    Tangirala, Muralikrishna
    Davies, Elizabeth Hackney
    O'Day, Ken
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (24) : 2110 - 2114
  • [6] A Clinical and Economic Comparison of Rasburicase and Allopurinol in the Treatment of Patients With Clinical or Laboratory Tumor Lysis Syndrome
    Cairo, Mitchell S.
    Thompson, Stephen
    Tangirala, Krishna
    Eaddy, Michael T.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (03): : 173 - 178
  • [7] Rasburicase for Tumor Lysis Syndrome
    Vishwanathan, Swati
    Arumugarajah, Aravindhan
    Ortega, Luis M.
    Bousamra, Alex
    AMERICAN JOURNAL OF THERAPEUTICS, 2019, 26 (01) : E118 - E121
  • [8] Prevention and treatment of tumor lysis syndrome in the rasburicase era
    Galardy, P. J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 : 1 - 2
  • [9] Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase
    Alakel, Nael
    Middeke, Jan Moritz
    Schetelig, Johannes
    Bornhaeuser, Martin
    ONCOTARGETS AND THERAPY, 2017, 10 : 597 - 605
  • [10] Rational use of rasburicase for the treatment and management of tumor lysis syndrome
    Shaikh, Suhail A.
    Marini, Bernard L.
    Hough, Shannon M.
    Perissinotti, Anthony J.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (03) : 176 - 184
12345